Associate Professor, Medicine, University of Vermont College of Medicine
Oncology
Dr. Marc S. Greenblatt, MD
|
|
Give Review
Marc Greenblatt is an expert in the field of Oncology. He researched medicine at Jefferson Medical College. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Marc Greenblatt is a published doctor as well. He has 53 publications published. The latest was: Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Marc Greenblatt accepts Medicare payments and is registered with Medicare.gov.
Publications
- Germline & somatic mosaicism: the 2014 annual scientific meeting of the human genome variation society.
- Spindle microtubule dysfunction and Cancer predisposition.
- The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
- Clinically relevant variants - identifying, collecting, interpreting, and disseminating: the 2013 annual scientific meeting of the human genome variation society.
- Classifying the Effects of BRCA1 and BRCA2 Variants on Splicing - A Systematic Study.
- Getting Ready for the Human Phenome Project: The 2012 Forum of the Human Variome Project.
- Familial multiple pilomatrixomas as a presentation of attenuated adenomatosis polyposis coli.
- Mutation (variation) databases and registries: a rationale for coordination of efforts.
- Classifying variants of CDKN2A using computational and laboratory studies.
- Clarity and claims in variation/mutation databasing.
- Mutation clusters offer insight into predicting pathogenicity.
- GENETICS. The Human Variome Project.
- Interpreting missense variants: comparing computational methods in human Disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR).
- An automated procedure to identify biomedical articles that contain Cancer-associated gene variants.
- Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung Cancer.
- The CDKN2A database: Integrating allelic variants with evolution, structure, function, and Disease association.
- Scanning Tunneling Microscopy and Nanolithography on a ConDucting Oxide, Rb0.3MoO3.
- Somatic point mutations in the p53 gene of human tumors and Cell lines: updated compilation.
- Comparison of doctor and patient assessments of asthma control.
- Deletions and insertions in the p53 tumor suppressor gene in human Cancers: confirmation of the DNA polymerase slippage/misalignment model.
- p16INK4 mutations and altered expression in human tumors and Cell lines.
- Mutational spectrum of the p53 tumor suppressor gene: clues to Cancer etiology and molecular pathogenesis.
- Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
- Molecular genetics of lung Cancer.
- p53 tumor suppressor gene: implications for iatrogenic Cancer and Cancer therapy.
- Database of p53 gene somatic mutations in human tumors and Cell lines.
- Mutations in the p53 tumor suppressor gene: clues to Cancer etiology and molecular pathogenesis.
- Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features.
- Database of p53 gene somatic mutations in human tumors and Cell lines: updated compilation and future prospects.
- Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin Cancers in Xpc and Xpc Trp53 mutant mice.
- Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
- Defective nucleotide excision repair in xpc mutant mice and its association with Cancer predisposition.
- Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
- Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1.
- Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification.
- Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric Cancer.
- A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publi...
- TP53 mutations in breast Cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.
- Detailed computational study of p53 and p16: using evolutionary sequence Analysis and disease-associated mutations to predict the functional consequences of allelic va...
- Recommendations for locus-specific databases and their curation.
- Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among Cancer patients.
- Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal Cancer patients with small bowel Cancer: International Society for Gastrointestinal ...
- Assessment of functional effects of unclassified genetic variants.
- Sequence variant classification and reporting: recommendations for improving the interpretation of Cancer susceptibility genetic test results.
- In silico Analysis of missense substitutions using sequence-alignment based methods.
- Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in Cancer susceptibility genes.
- Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.
- Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
- Planning the human variome project: the Spain report.
- Deciphering the colon Cancer genes--report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010.
- How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010.
- Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs).
Schools
Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
University Nm Hospital
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of New Mexico -
Jefferson Medical College
Drug Facts
| NPI NUMBER | 1770654550 | |
| NPPES Provider LastName | GREENBLATT | |
| NPPES Provider FirstName | MARC | |
| NPPES Provider ZIPCode | 054011473 | |
| NPPES Provider State | VT | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 223.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 11.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770654550 |
| Last Name Of The Provider | GREENBLATT |
| First Name Of The Provider | MARC |
| View All |
Similar Doctors
|
|
Dr. Johannes C. Nunnink, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Pillemer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Valentine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhuri V. Vithala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carleton R. Haines, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kim L. Dittus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie E. Wood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claire F. Verschraegen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jagoda K. Jasielec, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samir Ambrale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Gurpreet S. Lamba, MB BS
This Doctor is OpenDoctor Recommended.
|